Coronavirus (SARS-CoV-2): Measures at CECAD

16.11.2021 | News and Calendar

Latest notifications, rules and regulations regarding SARS-CoV-2

Study on the effectiveness of the ‘booster shot’ against the coronavirus launched

09.11.2021 | TopNews Prof. Oliver Cornely

The European Vaccination Research Network VACCELERATE, which is coordinated by the University of Cologne, is beginning a…

New overview of RNA binding molecules and their role in kidney disease

03.11.2021 | TopNews Prof. Dr. Thomas Benzing Prof. Dr. Roman-Ulrich Müller

Roman-Ulrich Müller and his team introduce new concept to kidney research | Publication in Nature Reviews Nephrology

Leo Kurian awarded the BINDER Innovation Prize 2021

29.10.2021 | TopNews Dr. Leo Kurian

The German Society for Cell Biology (DGZ) acknowledges each year outstanding cell biological research with a focus on cell culture…

Light Up for Mito: CECAD Research Center lights up green

22.09.2021 | TopNews Prof. Dr. Elena I. Rugarli

On Saturday, 25 September, Collaborative Research Center 1218, which studies Mitochondrial Regulation of Cellular Function, and…

Fountain of youth for aging stem cells in bone marrow

13.09.2021 | TopNews Discover Prof. Dr. Linda Partridge Dr. Peter Tessarz

Epigenetic changes in old age increase risk of osteoporosis and bone fractures

Welcome to two new W3 Professors at CECAD

01.09.2021 | TopNews

Filipe Cabreiro and Christian Frezza start their work in Cologne

Soapbox Science Rhineland: Female scientists explain their research on Rudolfplatz in Cologne

13.08.2021 | TopNews

On August 21, female scientists will present their research to passers-by on Rudolfplatz in Cologne.

Scientists discover new regulators of the aging process

28.07.2021 | TopNews Discover Prof. Dr. Marcus Krüger Prof. Dr. David Vilchez

The attachment of the small protein ubiquitin to other proteins (ubiquitination) regulates numerous biological processes,…

More than 5 million euros for kidney research

23.07.2021 | TopNews Prof. Dr. Thomas Benzing

Second funding period for KFO 329 approved